Transdermal analyte monitoring systems and methods for analyte detection

• US 8,812,071 B2
• Filed: 03/06/2008
• Issued: 08/19/2014
• Est. Priority Date: 03/07/2007
• Status: Expired due to Fees

• Current Assignee: Echo Therapeutics Incorporated
• Original Assignee: Echo Therapeutics Incorporated
• Inventors: Chuang, Han, Hurley, James P., Kost, Joseph
• Primary Examiner(s): D'ANGELO, MICHAEL J
• Application Number:
  US12/043,469
• Publication Number:
  US 20080281178A1
• Time in Patent Office: 2,357 Days
• Field of Search: 600/316, 600345-348, 600/365
• US Class Current: 600/345
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1486 using enzyme electrodes, e.g. with immobilised oxidase
• CPC Class Codes: A61B 5/6833 Adhesive patches

Abstract

Transdermal analyte monitoring systems (TAMS) having increased longevity and improved analyte detection are described herein. Kits for use with the TAMS and methods of using the TAMS and kits are also described. In a preferred embodiment, the TAMS includes a protective, semi-permeable membrane covering the surface of the hydrogel. The protective, semi-permeable membrane contacts with the skin of a user and prevents contamination or fouling of the hydrogel. Optionally, the hydrogel comprises one or more humectants and/or an immobilized enzyme. In another preferred embodiment, the TAMS contains at least one channel or pocket for increasing the amount of oxygen provided to the hydrogel. In one embodiment, a method for improving analyte detection by the TAMS is provided. For example, after the skin porosity is increased by an appropriate pretreatment, a skin preparation wipe is applied to the treated skin area and then the TAMS is applied to the treated area.

Claims

1. A transdermal analyte monitoring system comprising:

a sensor assembly, wherein the sensor assembly comprises a hydrogel and a sensor body containing a plurality of electrodes, wherein the sensor body is in fluid communication with the hydrogel, wherein the hydrogel comprises a humectant and an enzyme, and wherein the humectant is in an effective amount to increase the performance longevity of the transdermal analyte monitoring system, as indicated by decreased signal drift, compared to the same system in the absence of the humectant, and

wherein the humectant is sodium pyrrolidone carboxylic acid (NaPCA).

2. The transdermal analyte monitoring system of claim 1, wherein the hydrogel comprises a polymer selected from the group consisting of polyethylene glycol diacrylate (PEGDA), agarose, polyethylene glycol diacrylate/polyethyleneimine (PEGDA-PEI), polyethylene glycol diacrylate-n-vinyl pyrrolidone (PEGDA-NVP), acrylate-polyethylene glycol-N-hydroxy succinimide (A-PEG-N), and blends and copolymers thereof.

3. The transdermal analyte monitoring system of claim 1, wherein the enzyme is oxidase enzyme.

4. The transdermal analyte monitoring system of claim 1, wherein the enzyme is covalently immobilized in the hydrogel.

5. The transdermal analyte monitoring system of claim 4, wherein the enzyme is covalently immobilized in the hydrogel using an A-PEG-N.

6. The transdermal analyte monitoring system of claim 1, wherein the sensor assembly comprises at least one channel or pocket for providing oxygen to the hydrogel.

7. The transdermal analyte monitoring system of claim 1, wherein the enzyme is immobilized in the hydrogel via non-covalent immobilization.

8. The transdermal analyte monitoring system of claim 1, further comprising a semi-permeable membrane on the surface of the hydrogel, wherein the membrane is in fluid communication with the hydrogel.

9. The transdermal analyte monitoring system of claim 8, wherein the hydrogel and the semi-permeable membrane form an interpenetrating polymer network.

10. A method for increasing analyte detection by a transdermal analyte monitoring system comprising:

(a) treating a region of skin of the user to increase permeability; and

(b) applying to the treated region of skin a transdermal analyte monitoring system comprising

a sensor assembly, wherein the sensor assembly comprises a hydrogel and a sensor body containing a plurality of electrodes, wherein the sensor body is in fluid communication with the hydrogel wherein the hydrogel comprises a humectant and an enzyme, and wherein the humectant is in an effective amount to increase the performance longevity of the transdermal analyte monitoring system, as indicated by decreased signal drift, compared to the same system in the absence of the humectant, and

wherein the humectant is sodium pyrrolidone carboxylic acid (NaPCA).

11. The method of claim 10, wherein the region of skin is treated in step (a) by a method selected from the group consisting of tape stripping, rubbing, sanding, abrasion, laser ablation, radio frequency (RF) ablation, the application of chemicals, sonophoresis, iontophoresis, electroporation, and the application of permeation enhancing agents.

12. The method of claim 10, further comprising providing an enhanced supply of oxygen to the hydrogel.

13. The method of claim 12, wherein the source of oxygen is air.

14. The method of claim 12, wherein the enzyme in the hydrogel is an oxidase enzyme.

15. The method of claim 10, further comprising after step (a) and prior to step (b), wiping the treated region of skin with a substrate comprising at least one reagent selected from the group consisting of water, ethanol, isopropanol and glycerol.

16. The method of claim 10, wherein the analyte to be detected is blood glucose, lactate or other analytes.